Apo-Sitagliptin/Metformin XR 1000 mg

APO-SITAGLIPTIN/METFORMIN XR 1000 MG is an extended-release tablet combining sitagliptin and metformin hydrochloride. This medication is commonly used to manage type 2 diabetes by helping to control blood sugar levels. It is manufactured by Apotex Inc. in Canada.

APO-SITAGLIPTIN/METFORMIN XR 1000 MG is typically used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. The combination of sitagliptin and metformin works to lower blood sugar levels by different mechanisms. Sitagliptin helps to increase insulin production while metformin reduces glucose production in the liver. This dual-action approach can be beneficial for those who need additional support in managing their diabetes.

Common effects of APO-SITAGLIPTIN/METFORMIN XR 1000 MG may include gastrointestinal issues such as diarrhea, nausea, and abdominal discomfort. Some individuals might experience headaches or dizziness. These effects can vary from person to person and are not experienced by everyone who takes the medication.

It is important to handle APO-SITAGLIPTIN/METFORMIN XR 1000 MG with care, especially if you have certain medical conditions like kidney or liver problems. Always follow the guidance of a healthcare professional regarding its use. Keep the medication out of reach of children and store it as directed to maintain its effectiveness.

APO-SITAGLIPTIN/METFORMIN XR 1000 MG may interact with other medications, including those that affect kidney function or blood sugar levels. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.